British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitis-Reference-Cited by-同舟云学术

British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitis

Published:2020-07 Issue:7 Volume:5 Page:679-697
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Powell Nick,Ibraheim Hajir,Raine Tim,Speight Richard A,Papa Sophie,Brain Oliver,Green Michael,Samaan Mark A,Spain Lavinia,Yousaf Nadia,Hunter Nikki,Eldridge Lucy,Pavlidis Polychronis,Irving Peter,Hayee Bu'Hussain,Turajlic Samra,Larkin James,Lindsay James O,Gore Martin

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference145 articles.

1. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma;Robert;N Engl J Med,2011

2. Pembrolizumab versus ipilimumab in advanced melanoma;Robert;N Engl J Med,2015

3. Nivolumab in previously untreated melanoma without BRAF mutation;Robert;N Engl J Med,2015

4. Nivolumab versus everolimus in advanced renal-cell carcinoma;Motzer;N Engl J Med,2015

5. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer;Reck;N Engl J Med,2016

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Checkpoint Inhibitors Colitis;Decision Making in Gastroenterology;2025

2. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU;Gastroenterología y Hepatología;2024-04

3. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU;Gastroenterología y Hepatología (English Edition);2024-04

4. Updates in the pathogenesis and management of immune-related enterocolitis, hepatitis and cardiovascular toxicities;Immuno-Oncology and Technology;2024-03

5. Infliximab rescue therapy in a case of severe granulomatous colitis associated with rituximab use;BMJ Case Reports;2024-02